The role of histone acetylation in mediating the anticancer effects of polyphenols: Insights from genistein, resveratrol, quercetin, curcumin, and epigallocatechin-3-gallate
Authors:
Open Access
- 3 April 2026
- journal article
- review article
- Published by Elsevier in Cancer Treatment and Research Communications
- Vol. 47, 101195
Abstract
No abstract availableKeywords
This publication has 80 references indexed in Scilit:
- The Potential of Resveratrol as an Anticancer Agent: Updated Overview of Mechanisms, Applications, and PerspectivesArchiv der Pharmazie, 2025
- Pembrolizumab, radiotherapy, and an immunomodulatory five-drug cocktail in pretreated patients with persistent, recurrent, or metastatic cervical or endometrial carcinoma: Results of the phase II PRIMMO studyCancer Immunology, Immunotherapy, 2022
- The role of resveratrol, Sirtuin1 and RXRα as prognostic markers in ovarian cancerArchives of Gynecology and Obstetrics, 2021
- Multicenter randomized phase II study comparing docetaxel plus curcumin versus docetaxel plus placebo in first‐line treatment of metastatic castration‐resistant prostate cancerCancer Medicine, 2021
- Resveratrol modulates epigenetic regulators of promoter histone methylation and acetylation that restores BRCA1, p53, p21CIP1 in human breast cancer cell linesBioFactors, 2019
- Genistein combined with FOLFOX or FOLFOX–Bevacizumab for the treatment of metastatic colorectal cancer: phase I/II pilot studyCancer Chemotherapy and Pharmacology, 2019
- Green tea–induced epigenetic reactivation of tissue inhibitor of matrix metalloproteinase‐3 suppresses prostate cancer progression through histone‐modifying enzymesMolecular Carcinogenesis, 2019
- Synergistic anticancer action of quercetin and curcumin against triple‐negative breast cancer cell linesJournal of Cellular Physiology, 2018
- Genistein sensitizes inhibitory effect of tamoxifen on the growth of estrogen receptor‐positive and HER2‐overexpressing human breast cancer cellsMolecular Carcinogenesis, 2007
- Comparison of the effects of the chemopreventive agent resveratrol and its synthetic analog trans 3,4,5,4′‐tetramethoxystilbene (DMU‐212) on adenoma development in the ApcMin+ mouse and cyclooxygenase‐2 in human‐derived colon cancer cellsInternational Journal of Cancer, 2005